Ultherapy PRIME‘s global commercial rollout began in 2026 after late 2025 FDA clearance for new body areas like arms and abdomen. This next-generation platform offers 20% faster treatments, advanced DeepSEE visualization with 20% more clarity, and optimized DS 10-1.5N/DS 7-4.5 transducers for precise energy at 1.5mm/4.5mm depths, reducing discomfort.

ULTHERA DS 7-4.5 Transducer | Genuine Ultherapy | ALLWILL

What Is Ultherapy PRIME?

Ultherapy PRIME is Merz Aesthetics’ advanced nonsurgical skin lifting platform, FDA-cleared for face, neck, décolleté, arms, and abdomen. It uses microfocused ultrasound with real-time DeepSEE imaging to stimulate collagen production precisely.

This system builds on proven Ultherapy technology, delivering visible lifts in one session with no downtime. Practitioners benefit from a 35% larger screen for clearer images up to 8mm deep and dual-core processing for seamless operation. The DS 10-1.5N and DS 7-4.5 transducers ensure consistent energy delivery at targeted depths, enhancing patient comfort and results across diverse skin types.

How Does Ultherapy PRIME Differ from Original Ultherapy?

Ultherapy PRIME offers 20% faster treatment speeds, enhanced DeepSEE visualization with a 35% larger screen, and new body indications compared to original Ultherapy. Its modern operating system and ergonomic design support software updates for long-term use.

These upgrades reduce treatment times while maintaining high energy levels, increasing clinic efficiency. Patients experience less discomfort due to quieter operation and optimized transducers. The expanded capabilities make it versatile for comprehensive aesthetic protocols.

ALLWILL supports clinics transitioning with refurbished transducers via their Smart Center.

What Are Key Features of Ultherapy PRIME?

Ultherapy PRIME includes advanced DeepSEE visualization for 20% clearer tissue imaging, rapid energy delivery, and user-friendly ergonomics. Real-time ultrasound guides precise targeting at 1.5mm to 4.5mm depths.

The dual-core processor enables quick responses, while the 19-inch touchscreen minimizes operator errors. These features support personalized treatments yielding lifts lasting up to one year on the face and six months on the body. Consumables like DS transducers integrate seamlessly into high-volume practices.

What New Indications Does Ultherapy PRIME Cover?

Ultherapy PRIME is cleared for skin laxity on arms, abdomen, face, neck, and décolleté, making it the only real-time imaging solution for these body areas. This expands noninvasive lifting options for patients seeking toned contours.

Results develop gradually, with peak firmness at 3-6 months. Clinics can address more patient concerns without surgery, broadening service offerings and revenue streams.

Why Does Ultherapy PRIME Matter for Clinics?

Ultherapy PRIME drives clinic growth through faster sessions, 95% patient satisfaction, and versatile applications across body areas. Its ultrasound mechanism triggers natural collagen renewal for durable outcomes.

Real-time visualization ensures safety and efficacy for all skin types, reducing complications. B2B providers like ALLWILL facilitate adoption with cost-saving solutions and vetted support.

When and Where Is the Global Rollout Happening?

Ultherapy PRIME’s full global rollout launched in 2026 following U.S. availability and late 2025 clearances, with EMEA rollout early in the year and expansion to Asia-Pacific ongoing. Trained providers access it through Merz networks worldwide.

Also check:  How to Match Kavo, NSK, and W&H Handpiece Couplers for Aesthetic Lasers?

Major markets prioritize regions with high aesthetic demand, ensuring broad availability by mid-2026.

How Can Clinics Source Ultherapy PRIME Consumables?

Clinics source DS 10-1.5N and DS 7-4.5 transducers via authorized distributors or platforms like ALLWILL’s Lasermatch for new and refurbished options. ALLWILL’s Smart Center rigorously tests units to OEM standards.

Trade-up programs eliminate recertification costs, while MET connects users to certified technicians. This approach optimizes budgets and performance.

ALLWILL Expert Views

“Ultherapy PRIME sets a new benchmark in ultrasound lifting with superior speed and visualization. Our Smart Center at ALLWILL refurbishes PRIME transducers to peak efficiency, and Lasermatch ensures rapid global sourcing during the 2026 rollout. Through MET, we pair clinics with expert trainers for flawless implementation. ALLWILL transforms equipment challenges into strategic advantages for aesthetic leaders.”
— Dr. Elena Voss, ALLWILL Chief Medical Advisor (112 words)

What Results Can Patients Expect from Ultherapy PRIME?

Patients notice skin tightening starting 2-3 months after treatment, peaking at 6 months with effects lasting up to 1 year on the face and 6+ months on the body. A single session stimulates deep collagen without recovery time.

Mild redness fades quickly, delivering natural firmness against laxity.

Conclusion

Ultherapy PRIME’s 2026 rollout delivers faster, precise lifting with body expansions and unmatched visualization. Key takeaways include 20% speed improvements, optimized transducers, and proven longevity. Partner with ALLWILL for affordable new or refurbished systems, expert training via MET, and trade-ups to integrate this innovation and boost your practice.

FAQs

Is Ultherapy PRIME safe for all skin types?
Yes, its real-time imaging ensures safety across all skin tones, minimizing risks while targeting precise depths.

Also check:  What Are BTL Emsculpt Machine Indications, Protocols, and Ideal Patients?

How long do Ultherapy PRIME results last?
Face and neck results endure up to 1 year; body areas maintain firmness for 6+ months, based on individual factors.

What improves DeepSEE in Ultherapy PRIME?
A 35% larger screen, 20% clearer imaging, and noise reduction enable superior tissue visualization.

Can clinics access refurbished PRIME parts?
ALLWILL’s Smart Center supplies tested refurbished transducers, delivering cost savings and reliability.

When was body clearance granted for PRIME?
Late 2025 FDA clearance for arms and abdomen paved the way for 2026 global expansion.